Aeglea BioTherapeutics (AGLE) Shares Skyrocket Following Successful Acquisition of Spyre Therapeutics
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company has successfully acquired Spyre Therapeutics, a biotechnology company that focuses on […]